JP3382149B2 - External preparation for head - Google Patents
External preparation for headInfo
- Publication number
- JP3382149B2 JP3382149B2 JP04139098A JP4139098A JP3382149B2 JP 3382149 B2 JP3382149 B2 JP 3382149B2 JP 04139098 A JP04139098 A JP 04139098A JP 4139098 A JP4139098 A JP 4139098A JP 3382149 B2 JP3382149 B2 JP 3382149B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- hair
- agaricus mushroom
- mushroom mycelium
- agaricus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims description 22
- 241000222518 Agaricus Species 0.000 claims description 70
- 239000000284 extract Substances 0.000 claims description 65
- 239000000706 filtrate Substances 0.000 claims description 36
- 239000001296 salvia officinalis l. Substances 0.000 claims description 14
- 235000002020 sage Nutrition 0.000 claims description 13
- 244000025221 Humulus lupulus Species 0.000 claims description 12
- 244000042664 Matricaria chamomilla Species 0.000 claims description 12
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 12
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 12
- 240000002657 Thymus vulgaris Species 0.000 claims description 11
- 235000007303 Thymus vulgaris Nutrition 0.000 claims description 11
- 235000008694 Humulus lupulus Nutrition 0.000 claims description 9
- 241001529742 Rosmarinus Species 0.000 claims description 9
- 239000001585 thymus vulgaris Substances 0.000 claims description 8
- 240000007164 Salvia officinalis Species 0.000 claims description 7
- 241000086254 Arnica montana Species 0.000 claims description 6
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 6
- 241000546188 Hypericum Species 0.000 claims description 6
- 241000782597 Hypericum erectum Species 0.000 claims description 6
- 235000017309 Hypericum perforatum Nutrition 0.000 claims description 6
- 244000246386 Mentha pulegium Species 0.000 claims description 6
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 6
- 241001479543 Mentha x piperita Species 0.000 claims description 6
- 235000001050 hortel pimenta Nutrition 0.000 claims description 6
- 239000001771 mentha piperita Substances 0.000 claims description 6
- 235000002912 Salvia officinalis Nutrition 0.000 claims description 5
- 241001327634 Agaricus blazei Species 0.000 claims description 4
- 235000018978 Mentha arvensis Nutrition 0.000 claims description 4
- 240000007707 Mentha arvensis Species 0.000 claims description 4
- 241000894007 species Species 0.000 claims description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 69
- 238000004519 manufacturing process Methods 0.000 description 52
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 42
- 210000004209 hair Anatomy 0.000 description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 30
- 239000008213 purified water Substances 0.000 description 24
- 238000000605 extraction Methods 0.000 description 22
- 230000003779 hair growth Effects 0.000 description 22
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- 201000004384 Alopecia Diseases 0.000 description 17
- 210000003128 head Anatomy 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- 239000002904 solvent Substances 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 12
- -1 derivatives thereof Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 239000000419 plant extract Substances 0.000 description 12
- 239000000843 powder Substances 0.000 description 11
- 239000002244 precipitate Substances 0.000 description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 230000003676 hair loss Effects 0.000 description 9
- 208000024963 hair loss Diseases 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 239000003205 fragrance Substances 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 238000005119 centrifugation Methods 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 6
- 230000000259 anti-tumor effect Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 229940098465 tincture Drugs 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 4
- 241000208983 Arnica Species 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 235000014435 Mentha Nutrition 0.000 description 4
- 241001072983 Mentha Species 0.000 description 4
- 244000178231 Rosmarinus officinalis Species 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 231100000360 alopecia Toxicity 0.000 description 4
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 235000015639 rosmarinus officinalis Nutrition 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 210000004761 scalp Anatomy 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- 108010029908 3-oxo-5-alpha-steroid 4-dehydrogenase Proteins 0.000 description 3
- 102000001779 3-oxo-5-alpha-steroid 4-dehydrogenase Human genes 0.000 description 3
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 206010068168 androgenetic alopecia Diseases 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 229940008396 carrot extract Drugs 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000012136 culture method Methods 0.000 description 3
- 238000004042 decolorization Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 3
- 239000000417 fungicide Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 230000003658 preventing hair loss Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 229960003604 testosterone Drugs 0.000 description 3
- 230000003813 thin hair Effects 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 2
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 2
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 2
- 239000006000 Garlic extract Substances 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 2
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 235000017276 Salvia Nutrition 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 229940069521 aloe extract Drugs 0.000 description 2
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229960002684 aminocaproic acid Drugs 0.000 description 2
- 229960003473 androstanolone Drugs 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- 229960001950 benzethonium chloride Drugs 0.000 description 2
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 2
- 229960003260 chlorhexidine Drugs 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 238000004332 deodorization Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229930182833 estradiol Natural products 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 229960003399 estrone Drugs 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 229960002568 ethinylestradiol Drugs 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 235000020706 garlic extract Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000003410 keratolytic agent Substances 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 229960000448 lactic acid Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000003915 liquefied petroleum gas Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 229960003632 minoxidil Drugs 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000003169 placental effect Effects 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 230000003405 preventing effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 229960001755 resorcinol Drugs 0.000 description 2
- 229940112950 sage extract Drugs 0.000 description 2
- 235000020752 sage extract Nutrition 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 239000000021 stimulant Substances 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 229940043810 zinc pyrithione Drugs 0.000 description 2
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 2
- 229930007845 β-thujaplicin Natural products 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- ZESRJSPZRDMNHY-YFWFAHHUSA-N 11-deoxycorticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 ZESRJSPZRDMNHY-YFWFAHHUSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- 239000002677 5-alpha reductase inhibitor Substances 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 241000222501 Agaricaceae Species 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 241000218228 Humulus Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 235000017945 Matricaria Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000275031 Nica Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 229940089116 arnica extract Drugs 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- XQSLKIBWQSTAGK-UHFFFAOYSA-N carpronium Chemical compound COC(=O)CCC[N+](C)(C)C XQSLKIBWQSTAGK-UHFFFAOYSA-N 0.000 description 1
- 229950005472 carpronium Drugs 0.000 description 1
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 description 1
- 229950003631 carpronium chloride Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229960000978 cyproterone acetate Drugs 0.000 description 1
- UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 description 1
- ZESRJSPZRDMNHY-UHFFFAOYSA-N de-oxy corticosterone Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 ZESRJSPZRDMNHY-UHFFFAOYSA-N 0.000 description 1
- 229940119740 deoxycorticosterone Drugs 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 229940093476 ethylene glycol Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229940105902 mint extract Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 235000020737 peppermint extract Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
- 229960002256 spironolactone Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229940095585 testosterone-5-alpha reductase inhibitors for benign prostatic hypertrophy Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Description
【発明の詳細な説明】
【0001】
【発明の属する技術分野】本発明は、脱毛防止作用,発
毛効果などの養毛作用が相乗的に向上した養毛剤等の頭
部用外用剤に関し、更に詳しくは、アガリクス茸(Agar
icus blazei Murill)菌糸体の抽出物及び培養濾液より
選択される1種又は2種以上と、セージ(Salvia offic
inalis L.),ホップ(Humulus lupulus L.),ローズ
マリー(Rosmarinus officinalis L.),オトギリソウ
(Hypericum erectum Thunb.),ハッカ(Mentha arven
sis L. var. piperascens Malinv.),セイヨウハッカ
(Mentha piperita L.),カミツレ(Matricaria chamo
milla L.),アルニカ(Arnicamontana L.),タイム
(Thymus vulgaris L.)の各抽出物より選択される1種
又は2種以上とを有効成分として含有して成る頭部用外
用剤に関するものである。
【0002】
【従来の技術】脱毛症は、栄養摂取不良、フケの過剰発
生による頭皮生理機能の低下、頭皮皮下組織,末梢血管
の血流量減少に起因する毛包,毛球部の新陳代謝機能の
低下、及び精神的ストレス等、様々な原因により発生す
る。
【0003】かかる脱毛症を治療,改善するために、エ
ストロン,エストラジオール,エチニルエストラジオー
ル等の卵胞ホルモン、ビタミンE及びその誘導体,セン
ブリ抽出物,ニンニク抽出物,ニンジン抽出物,アロエ
抽出物,セファランチン,塩化カルプロニウム,ミノキ
シジル等の末梢血管血流促進剤、トウガラシチンキ,カ
ンタリスチンキ,ショウキョウチンキ,ハッカ油,l-メ
ントール,カンフル等の局所刺激剤、レゾルシン,サリ
チル酸,乳酸等の角質溶解剤、ピリドキシン及びその誘
導体等の抗脂漏剤、ジンクピリチオン,塩化ベンザルコ
ニウム,塩化ベンゼトニウム,クロルヘキシジン,ヒノ
キチオール等の殺菌剤、パントテン酸及びその誘導体,
胎盤抽出物,ビオチン,ペンタデカン酸グリセリド等の
毛根賦活剤、グリチルリチン酸及びその誘導体,β-グ
リチルレチン酸,アラントイン,アズレン,ε-アミノ
カプロン酸,ヒドロコルチゾン等の抗炎症剤、ビタミン
A,B2,B12,D等のビタミン剤、システイン,セリ
ン,メチオニン,ロイシン,トリプトファン等のアミノ
酸類等、多くの育毛,養毛成分が使用されてきた。
【0004】さらに、主として男性型脱毛症の治療,改
善を目的として、テストステロンから活性型のジヒドロ
テストステロンへの変換を触媒するテストステロン5α-
リダクターゼの活性を阻害するものが、多くスクリーニ
ングされてきた。前記酵素の阻害剤としては、プロゲス
テロン,デオキシコルチコステロン等のステロイド物質
の他、多種の植物の抽出物が知られている。また、オキ
センドロン,スピロノラクトン,酢酸シプロテロン等は
ジヒドロテストステロンがその受容体に結合するのを阻
害するといわれている。
【0005】しかしながら、従来用いられている上記の
育毛,養毛成分やテストステロン5α-リダクターゼ阻害
剤の中には、副作用があるため配合可能な量が制限され
たり、効果が不十分であったり、養毛剤等頭部用外用剤
製剤中での安定性が悪かったり、或いは一定の品質のも
のを得るのが困難であるといった問題を有するものが少
なくなかった。
【0006】
【発明が解決しようとする課題】そこで本発明において
は、男性型脱毛症の他、種々の原因により生じる薄毛や
脱毛症に適用可能で、脱毛防止作用及び発毛,養毛作用
が相乗的に向上し、且つ頭皮に対し安全性の高い養毛剤
等の頭部用外用剤を提供することを目的とする。
【0007】
【課題を解決するための手段】上記課題を解決するべく
種々検討を行ったところ、アガリクス茸(Agaricus bla
zei Murill)菌糸体の抽出物及び培養濾液より選択され
る1種又は2種以上と、セージ(Salvia officinalis
L.),ホップ(Humulus lupulus L.),ローズマリー
(Rosmarinus officinalis L.),オトギリソウ(Hyper
icum erectum Thunb.),ハッカ(Mentha arvensis L.
var. piperascens Malinv.),セイヨウハッカ(Mentha
piperita L.),カミツレ(Matricaria chamomilla
L.),アルニカ(Arnica montana L.),タイム(Thymu
s vulgaris L.)の各抽出物より選択される1種又は2
種以上とを併用することにより、脱毛防止及び発毛,養
毛作用が相乗的に向上することを見いだした。また、ア
ガリクス茸(Agaricus blazei Murill)菌糸体の抽出物又
は培養濾液、及びセージ等の各抽出物はそれぞれ低濃度
の配合で十分有効な作用を示すため、皮膚刺激性,接触
感作性といった皮膚への悪影響も見られず、さらに両者
とも安定な品質を示していた。
【0008】アガリクス茸(Agaricus blazei Murill)
は、担子菌類ハラタケ目ハラタケ科ハラタケ属の一種
で、カワリハラタケやヒメマツタケとも呼ばれる。アガ
リクス茸は北米の南東部及び南米に分布し、ブラジル東
南部においては昔から住民が食用としていた茸の一種で
ある。このアガリクス茸の有効性については特にその抗
腫瘍活性について多くの報告がなされている。例えば、
アガリクス茸の子実体或いは菌糸体を水性溶媒で抽出す
ることにより抗腫瘍作用を有する多糖類が得られること
(特開昭55−74797号公報,特開昭55−108
292号公報,特開平1−67194号公報,特開平1
−67195号公報,特開平6−128164号公報
等)、アガリクス茸の子実体から抗腫瘍作用を有する核
酸成分が得られること(特開平1−66127号公
報)、アガリクス茸の熱水抽出残渣から抗腫瘍活性を有
する蛋白多糖体が単離されること(特開平2−7863
0号公報)、アガリクス茸の85%エタノール抽出残渣
から抗腫瘍活性を有する糖蛋白質が得られること(特開
平6−9423号公報)、アガリクス茸子実体中に存在
する抗腫瘍活性を有するエルゴステロール誘導体(特開
平1−246299号公報)等が開示されている。また
アガリクス茸の生理活性として、アガリクス茸子実体抽
出物を有効成分とする肝機能改善剤(特開平2−124
829号公報)、アガリクス茸菌糸体培養抽出物の抗ア
レルギー作用(特開平1−228480号公報)、アガ
リクス茸子実体抽出物の免疫能低下改善作用(特開平7
−258107号公報)等が報告されている。さらに、
アガリクス茸菌糸体抽出物又は培養濾液が毛根活性化作
用を有することについて、すでに開示した(特願平9−
367848)。
【0009】一方、セージ(Salvia officinalis
L.),ホップ(Humulus lupulus L.),ローズマリー
(Rosmarinus officinalis L.),オトギリソウ(Hyper
icum erectum Thunb.),ハッカ(Mentha arvensis L.
var. piperascens Malinv.),セイヨウハッカ(Mentha
piperita L.),カミツレ(Matricaria chamomilla
L.),アルニカ(Arnica montana L.),タイム(Thymu
s vulgaris L.)の各抽出物より選択される1種又は2
種以上については、テストステロン5α-リダクターゼ阻
害活性を有することも開示されている(特公平6−47
554号公報)。
【0010】今回本発明者は、アガリクス茸菌糸体の溶
媒抽出物及び培養濾液より選択される1種又は2種以上
と、セージ(Salvia officinalis L.),ホップ(Humul
us lupulus L.),ローズマリー(Rosmarinus officina
lis L.),オトギリソウ(Hypericum erectum Thun
b.),ハッカ(Mentha arvensis L. var. piperascens
Malinv.),セイヨウハッカ(Mentha piperita L.),
カミツレ(Matricaria chamomilla L.),アルニカ(Ar
nica montana L.),タイム(Thymus vulgaris L.)の
各抽出物より選択される1種又は2種以上とを併用して
養毛剤等の頭部用外用剤基剤に含有させることにより、
脱毛防止作用及び発毛,養毛作用が相乗的に向上するこ
とを見いだし、本発明を完成するに至った。
【0011】
【発明の実施の形態】本発明で用いるアガリクス茸(Aga
ricus blazei Murill)は、すでに広く知られており、工
業技術院生命工学工業技術研究所に寄託番号、生命研菌
寄第4731号として寄託されている。
【0012】アガリクス茸菌糸体の培養法としては、担
子菌の培養に通常用いられる固体培養法及び液体培養法
のいずれを採用してもよいが、後者の方法が生産性の点
から好ましく用いられる。培養用培地としては、菌糸体
の発育に必要な諸栄養が含まれていればよく、通常の培
地が使用できる。すなわち、炭素源としては、グルコー
ス,ショ糖,マルトース,デンプンなど資化し得る炭素
源であれば利用できる。窒素源としては、例えば硫酸ア
ンモニウム塩,硝酸アンモニウム塩,尿素等、天然の複
合栄養源としては、例えばジャガイモエキス,ニンジン
エキス,麦芽エキス,ペプトン,コウジエキス,酵母エ
キス,酵母末等を用いることができ、その他成長に必要
な微量元素無機塩類,ビタミン類などを適宜添加して用
いる。
【0013】培養は、通常好気的条件下で行うのが好ま
しく、例えば振とう培養法或いは通気攪拌培養法が用い
られる。培養中の攪拌は、24時間毎に数分間往復振と
う又は回転振とうすればよいが、連続振とうしてもよ
い。培養温度は15℃〜40℃、好ましくは20℃〜3
0℃前後である。培地のpHは3.0〜9.0の範囲が
適切で、特に4.5〜7.0で生育が良好である。ま
た、培養中は照光しない方が好ましいが、1日11〜1
4時間程度の照光は可能である。
【0014】培養日数は培養温度,培地組成などの培養
条件によって異なるが、菌糸体の十分な生育が認められ
る期間であればよく、通常は2〜120日間、特に好ま
しくは5〜90日間で、菌糸体生産量が最大となる期間
を設定すればよい。
【0015】培養終了後培養液を遠心分離或いは濾過す
ることにより菌糸体と培養濾液を分離する。遠心分離は
100〜5,000G、好ましくは800〜3,000
Gの重力加速度を与える遠心操作により行うことができ
る。また濾過は、3.5〜200メッシュ、特に好まし
くは4〜16メッシュのメンブランフィルターなどを用
いて行う。
【0016】アガリクス茸の菌糸体から抽出物を得る場
合、上記の通り培養した培養液から得られた菌糸体をそ
のまま、或いは乾燥して用いることができる。菌糸体か
らの抽出溶媒としては、極性溶媒が好ましく用いられ
る。例えば、水の他、メタノール,エタノール,イソプ
ロパノール,イソブタノールなどのアルコール類、グリ
セリン,エチレングリコール,エチレングリコールモノ
メチルエーテル,エチレングリコールモノエチルエーテ
ル,プロピレングリコール,プロピレングリコールモノ
メチルエーテル,プロピレングリコールモノエチルエー
テル,トリエチレングリコール,1,3-ブチレングリコー
ル,ヘキシレングリコール等の多価アルコール又はその
誘導体、エチルエーテル,プロピルエーテル等のエーテ
ル類、酢酸エチル,酢酸ブチル等のエステル類、アセト
ン,エチルメチルケトン等のケトン類などから選択され
る1種又は2種以上の混合溶媒が使用できる。また、生
理食塩水,リン酸緩衝液,リン酸緩衝生理食塩水等を用
いてもよい。
【0017】さらに抽出方法としては、室温,冷却又は
加温下で抽出溶媒に含浸させて抽出する方法、水蒸気蒸
留等の蒸留法を用いて抽出する方法、生のアガリクス茸
菌糸体を直接圧搾して抽出物を得る圧搾法等が例示さ
れ、これらの方法を単独で又は2種以上を組み合わせて
抽出を行う。
【0018】抽出の際のアガリクス茸菌糸体と溶媒との
比率は特に限定されるものではないが、アガリクス茸菌
糸体1に対して溶媒0.5〜1,000重量倍、特に抽
出操作、効率の点で0.5〜100重量倍が好ましい。
また抽出温度は、常圧下で5℃程度から溶剤の沸点以下
の範囲とするのが便利であり、抽出時間は抽出温度など
抽出条件によって異なるが、2時間〜2週間の範囲とす
るのが好ましい。
【0019】また、このようにして得られたアガリクス
茸菌糸体抽出物は、抽出物をそのまま用いることもでき
るが、毛根活性化作用を失わない範囲内で分画、脱臭,
脱色,濃縮等の精製操作を加えて用いることもできる。
これらの抽出物,精製物及び分画物等は、濃縮乾固や凍
結乾燥により粉末状とすることができ、さらに精製水な
どの溶媒に可溶化、或いは懸濁して養毛剤等頭部用外用
剤に添加することもできる。
【0020】一方、濾別した菌糸体培養濾液も、そのま
ま頭部用外用剤に配合することができるが、やはり毛根
活性化作用を失わない範囲内で分画、脱臭,脱色,濃縮
などの精製操作を加えて用いることもできる。これらの
培養濾液やその精製物,分画物は、これらから溶媒を除
去することによって乾固物とすることもでき、さらに精
製水などの溶媒に可溶化又は懸濁した形態、或いは乳剤
の形態で頭部用外用剤に添加することができる。
【0021】これらのアガリクス茸菌糸体抽出物及び菌
糸体培養濾液より、1種又は2種以上を選択して養毛剤
等の頭部用外用剤に配合する。配合量としては、抽出方
法他の調製法により異なるが、バイオアベイラビリティ
や製剤への影響等を考慮して、0.0001〜10重量
%の濃度範囲とすることが適切である。
【0022】一方、セージ(Salvia officinalis L.)
等の植物抽出物は、これら植物を抽出溶媒中に浸漬して
得る。抽出には、各植物の花,葉,茎,根等の各部分及
び全草を用いることができる。これら植物はそのまま抽
出処理してもよいが、抽出効率を上げるためには、細
切,粉砕等した後抽出するか、抽出溶媒中でホモジネー
トすることが好ましい。抽出溶媒としては極性溶媒が好
ましく、水の他、メタノール,エタノール,プロパノー
ル,イソプロパノール,ブタノール等の低級アルコール
類、プロピレングリコール,ジプロピレングリコール,
1,3-ブチレングリコール,グリセリン等の多価アルコー
ル類、エチルエーテル,プロピルエーテル等のエーテル
類、酢酸エチル,酢酸ブチル等のエステル類、アセト
ン,エチルメチルケトン等のケトン類などが好ましいも
のとして挙げられ、これらより1種又は2種以上を選択
して用いる。また、リン酸緩衝液や生理食塩水,リン酸
緩衝生理食塩水も良好に用いることができる。テストス
テロン5α-リダクターゼ阻害活性の点からは、エタノー
ルによる抽出が特に好ましい。抽出温度としては5〜5
0℃程度、抽出時間としては4時間〜1週間程度が適切
である。
【0023】上記の植物抽出物は、そのまま養毛剤等の
頭部用外用剤基剤に添加してもよいが、濃縮,乾固した
ものを水や極性溶媒に再度溶解したり、テストステロン
5α-リダクターゼ阻害活性を損なわない範囲で脱色,脱
臭,脱塩等の精製処理を行った後に添加してもよい。ま
た、濃縮,乾固した後、或いは精製処理を行った後に、
凍結乾燥して粉末状として添加してもよい。
【0024】本発明においては、上記植物抽出物より1
種又は2種以上を選択して頭部用外用剤に配合する。配
合量としては、やはり抽出物のテストステロン5α-リダ
クターゼ阻害活性により異なるが、0.0001〜10
重量%程度とすることが適切である。
【0025】本発明に係る頭部用外用剤においては、有
効成分であるアガリクス茸菌糸体抽出物及び培養濾液よ
り選択される1種又は2種以上、及びセージ(Salvia o
fficinalis L.),ホップ(Humulus lupulus L.),ロ
ーズマリー(Rosmarinus officinalis L.),オトギリ
ソウ(Hypericum erectum Thunb.),ハッカ(Mentha a
rvensis L. var. piperascens Malinv.),セイヨウハ
ッカ(Mentha piperita L.),カミツレ(Matricaria c
hamomilla L.),アルニカ(Arnica montana L.),タ
イム(Thymus vulgaris L.)の各抽出物より選択される
1種又は2種以上の他に、さらに発毛、養毛促進効果を
高めるため、エストロン,エストラジオール,エチニル
エストラジオール等の卵胞ホルモン、ビタミンE及びそ
の誘導体,センブリ抽出物,ニンニク抽出物,ニンジン
抽出物,アロエ抽出物,セファランチン,塩化カルプロ
ニウム,ミノキシジル等の末梢血管血流促進剤、トウガ
ラシチンキ,カンタリスチンキ,ショウキョウチンキ,
ハッカ油,l-メントール,カンフル等の局所刺激剤、レ
ゾルシン,サリチル酸,乳酸等の角質溶解剤、ピリドキ
シン及びその誘導体等の抗脂漏剤、ジンクピリチオン,
塩化ベンザルコニウム,塩化ベンゼトニウム,クロルヘ
キシジン,ヒノキチオール等の殺菌剤、パントテン酸及
びその誘導体,胎盤抽出物,ビオチン,ペンタデカン酸
グリセリド等の毛根賦活剤、グリチルリチン酸及びその
誘導体,β-グリチルレチン酸及びその誘導体,アラン
トイン,アズレン,ε-アミノカプロン酸,ヒドロコル
チゾン等の抗炎症剤、ビタミンA,B2,B12,D等のビタ
ミン剤、システイン,セリン,メチオニン,ロイシン,
トリプトファン等のアミノ酸類等を同時に配合すること
ができる。
【0026】さらに本発明の効果を損なわない範囲内
で、油脂類,低級アルコール類,多価アルコール類,界
面活性剤,保湿剤,防菌防黴剤,紫外線吸収剤,香料,
色素類,顔料等、通常養毛剤等の頭部用外用剤に一般的
に使用される原料や添加剤を含有させることができる。
【0027】本発明に係る頭部用外用剤は、ローション
剤,乳剤,ゲル剤,クリーム,軟膏等の形態で提供する
ことができる。また、ヘアーローション,ヘアートニッ
ク,ヘアーミルク,ヘアージェル,ヘアークリーム,ヘ
アーパック,ヘアートリートメント,ヘアーシャンプ
ー,ヘアーリンスといった形態の頭部用化粧料としても
提供され得る。
【0028】
【実施例】さらに、実施例により本発明の特徴を詳細に
説明する。まず、本発明の実施例に使用したアガリクス
茸菌糸体抽出物,アガリクス茸菌糸体培養濾液及びセー
ジ等の植物抽出物の製造例を以下に示す。
【0029】[製造例1] アガリクス茸菌糸体抽出物
1
特公昭61−47518号公報明細書の実施例1に記載
された方法により、アガリクス茸菌糸体抽出物1を得
た。すなわち、グルコース4g,酵母エキス4g,麦芽
エキス10g及び精製水1,000mlから成るpH
5.5の培地に、寒天培地に培養したアガリクス茸菌糸
体を接種し、30℃で30日間、時々攪拌しながら静置
で前培養した。次いで、グルコース20g,酵母末5
g,消泡剤20ppm及び精製水1,000mlから成
るpH5.0の本培養培地2,000mlに、前培養し
た培地200mlを接種し、30℃で往復振とう機にて
30日間培養した。遠心分離により菌糸体を培養液より
分離し、菌糸体に対して7重量倍の精製水を加え、95
℃で2時間加熱抽出を行った。抽出液を遠心分離して得
られた上清をアガリクス茸菌糸体抽出物1(製造例1)
とした。
【0030】[製造例2] アガリクス茸菌糸体抽出物
2
上記のアガリクス茸菌糸体抽出物1を1/2容量に濃縮
し、エタノールを等容量加えて4℃で一昼夜静置し、沈
殿を生成させた。この沈殿を遠心分離により回収し、ア
セトン,次いでエーテルで洗浄後乾燥し、淡褐色粉末を
得た。これをアガリクス茸菌糸体抽出物2(製造例2)
とした。
【0031】[製造例3] アガリクス茸菌糸体抽出物
3
特公昭61−47518号公報明細書の実施例2に記載
された方法により、アガリクス茸菌糸体抽出物3を得
た。すなわち、グルコース20g,酵母エキス5g及び
精製水1,000mlから成るpH5.0の培地に、寒
天培地に培養したアガリクス茸菌糸体を接種し、30
℃,3週間静置で前培養した。この前培養液500ml
を、グルコース50g,酵母末10g,消泡剤20pp
m及び精製水1,000mlから成るpH5.0の本培
養培地3,000mlに接種し、培養温度30℃,通気
量0.5VVM,攪拌速度200〜300rpmの条件
にて培養した。10日間培養後、濾過して菌糸体を分
離,回収した。この菌糸体に精製水3,000mlを加
え、50℃で1時間加熱抽出した。冷却後、10,00
0rpmで30分間遠心分離し、上清をアガリクス茸菌
糸体抽出物3(製造例3)とした。
【0032】[製造例4] アガリクス茸菌糸体抽出物
4
アガリクス茸菌糸体抽出物3をロータリーエバポレータ
ーで減圧濃縮し、1,000mlとした。これにエタノ
ール1,000mlを加え、1昼夜4℃に静置して沈殿
を生成させた。次いで沈殿を回収し、アセトン,エーテ
ルで洗浄した後乾燥して淡灰白色の粉末を得た。さらに
これを精製水500mlに溶解し、透析チューブにて精
製水5,000mlに対して透析し、生じた沈殿物を遠
心分離で除去後、上清を凍結乾燥して白色粉末を得、こ
れをアガリクス茸菌糸体抽出物4(製造例4)とした。
【0033】[製造例5] アガリクス茸菌糸体培養濾
液1
製造例1の調製時に、アガリクス茸菌糸体の本培養液よ
り菌糸体を除去した後の培養液を、アガリクス茸菌糸体
培養濾液1(製造例5)とした。
【0034】[製造例6] アガリクス茸菌糸体培養濾
液分画物1
アガリクス茸菌糸体培養濾液1をロータリーエバポレー
ターで1/6容量まで濃縮し、これに等容量のエタノー
ルを添加して4℃で一昼夜静置し、沈殿を生成させた。
遠心分離により沈殿を回収し、アセトン,エーテルで洗
浄した後乾燥して淡褐色粉末を得、アガリクス茸菌糸体
培養濾液分画物1(製造例6)とした。
【0035】[製造例7] アガリクス茸菌糸体培養濾
液2
製造例3の調製時に、アガリクス茸菌糸体本培養液より
菌糸体を除去した後の培養液を、アガリクス茸菌糸体培
養濾液2(製造例7)とした。
【0036】[製造例8] アガリクス茸菌糸体培養濾
液分画物2
アガリクス茸菌糸体培養濾液2をロータリーエバポレー
ターにて1/10容量まで濃縮し、等容量のエタノール
を添加して1昼夜4℃で静置し、沈殿を生成させた。遠
心分離により沈殿を回収し、アセトン,エーテルで洗浄
した後乾燥して、淡褐色粉末を得た。これを精製水30
0mlに溶解し、透析チューブにて精製水3,000m
lに対して透析し、生じた沈殿物を遠心分離にて除去し
た後、上清を凍結乾燥して白色粉末を得、アガリクス茸
菌糸体培養濾液分画物2(製造例8)とした。
【0037】[製造例9〜製造例26]表1第2欄に示
す植物を細切し、表1第3欄の各溶媒中に20℃で3日
間浸漬して抽出を行った。抽出物を濾過して得た濾液
を、さらに表1第4欄に示す通り処理し、セージ等の抽
出物(製造例9〜製造例26)とした。
【表1】【0038】上記の製造例を用いて、アガリクス茸菌糸
体抽出物又は培養濾液と、セージ等の植物抽出物を併用
した場合の発毛促進作用を検討した。C57/Blac
kマウス背部をバリカンで2×4cmの大きさに毛刈り
し、脱毛フォームで処理して完全に除毛し、24時間経
過後より、表2に示す各試料溶液を1日1回0.1mlず
つ20日間連続塗布した。試験最終日に発毛した毛を全
て抜き取り、その総重量を測定した。試験は一群10匹
で行い、平均値を算出して表3に示した。その際、溶媒
の50重量%エタノール水溶液のみを塗布した群を対照
とした。
【表2】
【0039】
【表3】表3より明らかなように、製造例1〜製造例8のアガリ
クス茸菌糸体抽出物又は培養濾液、及び製造例9〜製造
例26の植物抽出物は、それぞれ単独で塗布した群にお
いても対照と比較して有意な発毛促進を示すが、これら
を併用した場合、発毛量は顕著に増加していた。
【0040】[実施例1〜実施例8] 養毛ローション
表4に示したアガリクス茸菌糸体抽出物又は培養濾液及
び植物抽出物を用いて、下記の処方により養毛ローショ
ンを調製した。
(処方)
(1)エタノール 50.00(重量%)
(2)ビタミンB6 0.10
(3)アガリクス茸菌糸体抽出物 0.05
又は培養濾液
(4)植物抽出物 0.50
(5)1,3-ブチレングリコール 2.50
(6)香料 0.10
(7)精製水 46.75
製法:(1)〜(6)を順次(7)に添加,混合し、均一とす
る。
【表4】
【0041】実施例1〜実施例8について使用試験を行
い、養毛効果を評価した。その際、前記実施例1,実施
例2,実施例5及び実施例6において、アガリクス茸菌
糸体抽出物又は培養濾液を精製水に代替したものを比較
例1,比較例2,比較例5及び比較例6、実施例3,実
施例4,実施例7及び実施例8において植物抽出物を精
製水に代替したものを比較例3,比較例4,比較例7及
び比較例8とし、さらにアガリクス茸菌糸体抽出物又は
培養濾液及び植物抽出物の双方を精製水に代替したもの
を比較例9として同様に試験を行った。使用試験は、薄
毛や脱毛の気になる男女パネラー20名を1群とし、実
施例及び比較例のそれぞれを各群にブラインドにて1日
2回、6ヶ月間連続して使用させ、薄毛や脱毛症状の改
善状況と、使用時の刺激感の有無について評価して行っ
た。薄毛や脱毛症状の改善状況は、使用試験開始前及び
終了後の毛髪の状態を写真撮影により表5に示す判定基
準に従って評価して点数化し、20名の平均値を算出し
た。使用時の刺激感については、「感じない;0点」,
「微妙に感じる;1点」,「少し感じる;2点」,「は
っきりと感じる;3点」,「非常に感じる;4点」とし
て点数化し、20名の平均値を求めた。以上の結果は表
6にまとめて示した。
【表5】
【0042】
【表6】
表6において明らかなように、本発明の実施例使用群で
は、各群でほとんどのパネラーにおいて全体的な生毛以
上の発毛及び毛髪の成長が認められており、さらに硬毛
を認めたパネラーも相当数存在するなど、非常に良好な
脱毛症状及び薄毛の改善が見られていた。これに対し、
アガリクス茸菌糸体抽出物又は培養濾液、或いは植物抽
出物のいずれか一方のみを含有する比較例1〜比較例8
塗布群では、脱毛症状及び薄毛の改善は認められたが、
その程度は各実施例塗布群に比べ小さいものであった。
アガリクス茸菌糸体抽出物又は培養濾液,植物抽出物の
いずれをも含有しない比較例9塗布群では、毛髪の状態
に有意な変化は認められなかった。
【0043】また使用時の刺激感については、本発明の
実施例1〜実施例8及び比較例1〜比較例9塗布群のい
ずれにおいても、特に問題となる刺激感は認められてい
なかった。
【0044】続いて、本発明の他の実施例の処方を示
す。
【0045】
[実施例9] 頭部用クリーム
(1)流動パラフィン 15.00(重量%)
(2)ワセリン 15.00
(3)ミツロウ 2.00
(4)ポリオキシエチレン(50E.O.)硬化ヒマシ油 3.00
(5)グリセリン 5.00
(6)カルボキシビニルポリマー 0.10
(7)キサンタンガム 0.10
(8)エチレンジアミン四酢酸二ナトリウム 0.10
(9)精製水 59.10
(10)水酸化ナトリウム 0.05
(11)アガリクス茸菌糸体抽出物1(製造例1) 0.25
(12)タイム抽出物(製造例25) 0.15
(13)セージ抽出物(製造例9) 0.15
製法;(1)〜(3)の油相を加熱溶解し、80℃とする。一
方(4)〜(9)の水相成分を混合,加熱溶解し、80℃とす
る。水相に油相を攪拌しながら加え、ホモジナイザーに
より均一に乳化し、冷却後30℃にて(10)を添加,混合
後、(11)〜(13)をあらかじめ混合,溶解して添加し、混
合,均一化する。
【0046】
[実施例10] 頭部用ゲル剤
(1)カルボキシビニルポリマー 0.7(重量%)
(2)ポリビニルピロリドン 2.0
(3)グリセリン 5.0
(4)水酸化ナトリウム 0.2
(5)エタノール 20.0
(6)エチレンジアミン四酢酸二ナトリウム 0.1
(7)精製水 70.8
(8)アガリクス茸菌糸体抽出物2(製造例2) 0.2
(9)ホップ抽出物(製造例11) 1.0
製法:(1)を(3)と(7)の一部に分散する。これに(2),
(4)〜(6)を(7)の残部に溶解して加え、更に(8)及び(9)
をあらかじめ混合,溶解して添加し、混合,均一化す
る。
【0047】
[実施例11] セットローション
(1)ポリビニルピロリドン・酢酸ビニル共重合体 5.00(重量%)
(2)パラオキシ安息香酸メチル 0.10
(3)香料 0.10
(4)エタノール 30.00
(5)ポリオキシエチレン・ポリオキシプロピレン変性 0.50
ジメチルポリシロキサン
(6)グリセリン 2.00
(7)アガリクス茸菌糸体抽出物3(製造例3) 0.01
(8)ローズマリー抽出物(製造例13) 0.25
(9)精製水 62.04
製法:(1)〜(3)を(4)に順次添加して溶解する。一方(5)
〜(9)の水相を混合,溶解し、前記溶液に加えて混合
し、均一とする。
【0048】
[実施例12] ヘアリキッド
(1)エタノール 50.00(重量%)
(2)ポリオキシプロピレン(40P.O.)ブチルエーテル 20.00
(3)ポリオキシエチレン(50E.O.)硬化ヒマシ油 1.00
(4)パラオキシ安息香酸メチル 0.15
(5)アガリクス茸菌糸体抽出物4(製造例4) 0.10
(6)オトギリソウ抽出物(製造例15) 0.50
(7)ハッカ抽出物(製造例17) 1.00
(8)香料 0.10
(9)青色1号(1%水溶液) 0.10
(10)精製水 27.05
製法:(1)に(2)〜(10)の成分を順次添加して溶解し、均
一化する。
【0049】
[実施例13] ウォーターグリース
(1)カルボキシビニルポリマー 0.5(重量%)
(2)グリセリン 50.0
(3)精製水 38.5
(4)ポリオキシエチレン(20E.O.)オクチルドデシル 0.2
エーテル
(5)水酸化ナトリウム 0.1
(6)エタノール 10.0
(7)アガリクス茸菌糸体培養濾液1(製造例5) 0.2
(8)アガリクス茸菌糸体培養濾液分画物2(製造例8) 0.2
(9)カミツレ抽出物(製造例21) 0.2
(10)香料 0.1
製法:(1)を(2)と(3)の一部に分散する。これに(4),
(6)〜(10)を(3)の残部に溶解して加え、次いで(5)を加
えて増粘させる。
【0050】
[実施例14] ヘアーフォーム
(原液処方)
(1)シリコーン油 5.00(重量%)
(2)ポリオキシエチレン(50E.O.)硬化ヒマシ油 1.00
(3)ジプロピレングリコール 7.00
(4)カチオン化セルロース 3.00
(5)精製水 67.00
(6)エタノール 15.00
(7)アガリクス茸菌糸体培養濾液分画物1(製造例6) 0.25
(8)セイヨウハッカ抽出物(製造例19) 1.50
(9)パラオキシ安息香酸メチル 0.15
(10)香料 0.10
(充填処方)
原液 90.0
液化石油ガス 10.0
製法:(1)を(2)と(3)の溶解物に添加し、ホモジナイザ
ーで均一に乳化する。これを(4),(6)〜(10)を(5)に溶
解した中に添加,混合して均一とし、これを原液とす
る。充填は缶に原液を充填し、バルブを装着した後、液
化石油ガスを充填して行う。
【0051】
[実施例15] ヘアーシャンプー
(1)ポリオキシエチレン(3E.O.)ラウリル硫酸 30.00(重量%)
エステルナトリウム塩(30重量%水溶液)
(2)ラウリル硫酸エステルナトリウム塩 10.00
(30重量%水溶液)
(3)ヤシ油脂肪酸ジエタノールアミド 4.00
(4)グリセリン 1.00
(5)デヒドロ酢酸ナトリウム 0.20
(6)エチレンジアミン四酢酸二ナトリウム 0.25
(7)精製水 53.55
(8)アガリクス茸菌糸体培養濾液2(製造例7) 0.50
(9)アルニカ抽出物(製造例23) 0.20
(10)タイム抽出物(製造例26) 0.20
(11)香料 0.10
製法:(7)を70℃に加熱し、(1)〜(6)を加え均一に溶
解した後冷却し、30℃で(8)〜(11)を添加,混合し、
均一とする。
【0052】
[実施例16] ヘアリンス
(1)シリコーン油 3.00(重量%)
(2)流動パラフィン 1.00
(3)セタノール 1.50
(4)ステアリルアルコール 1.00
(5)塩化ステアリルトリメチルアンモニウム 0.70
(6)グリセリン 3.00
(7)パラオキシ安息香酸メチル 0.20
(8)精製水 88.92
(9)アガリクス茸菌糸体抽出物2(製造例2) 0.02
(10)アガリクス茸菌糸体培養濾液分画物1(製造例6) 0.02
(11)セージ抽出物(製造例10) 0.02
(12)ホップ抽出物(製造例12) 0.02
(13)タイム抽出物(製造例26) 0.50
(14)香料 0.10
製法:(1)〜(4)の油相成分及び(5)〜(8)の水相成分をそ
れぞれ混合,溶解して70℃に加熱する。水相に油相を
添加して乳化し、冷却後30℃にて(9)〜(14)をあらか
じめ混合,溶解して添加し、混合,均一化する。
【0053】上記の本発明の実施例1〜実施例16は、
いずれも安定性は良好であり、25℃で6カ月間保存し
た場合にも、色,臭いの変化や相分離、析出物,沈降物
の出現といった状態の変化は全く認められなかった。ま
た、男性パネラーによる48時間の背部閉塞貼付試験の
結果、皮膚刺激性は全く認められなかった。
【0054】
【発明の効果】以上詳述したように、本発明により、男
性型脱毛症の他、種々の原因により生じる薄毛や脱毛症
に適用可能で、脱毛防止作用及び発毛,養毛作用が相乗
的に向上し、且つ頭皮に対し安全性の高い頭部用外用剤
を提供することができた。Description: BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an external preparation for the head such as a hair restorer having a synergistically improved hair growth effect such as a hair loss preventing effect and a hair growth effect. For more information, see Agaric Mushroom ( Agar
icus blazei Murill) One or more selected from mycelium extract and culture filtrate, and sage ( Salvia offic)
inalis L.), hops ( Humulus lupulus L.), rosemary ( Rosmarinus officinalis L.), hypericum ( Hypericum erectum Thunb.), mint ( Mentha arven )
sis L. var. piperascens Malinv.) , peppermint (Mentha piperita L.), chamomile (Matricaria chamo
milla L.), Arnicamontana L., Thymus vulgaris L., and one or more selected from extracts thereof as an active ingredient. is there. [0002] Alopecia is caused by poor nutritional intake, decreased scalp physiology due to excessive occurrence of dandruff, and decreased metabolic functions of hair follicles and hair bulbs caused by decreased blood flow in scalp subcutaneous tissues and peripheral blood vessels. It is caused by various causes such as deterioration and mental stress. In order to treat and improve such alopecia, estrogen such as estrone, estradiol, ethinyl estradiol, vitamin E and its derivatives, assembly extract, garlic extract, carrot extract, aloe extract, cepharanthin, chloride Peripheral vascular blood flow promoters such as carpronium and minoxidil, local stimulants such as pepper tincture, cantaris tincture, ginger tincture, peppermint oil, l-menthol, camphor, keratolytic agents such as resorcin, salicylic acid, lactic acid, pyridoxine and Antiseborrheic agents such as derivatives thereof, bactericides such as zinc pyrithione, benzalkonium chloride, benzethonium chloride, chlorhexidine, hinokitiol, pantothenic acid and derivatives thereof,
Placental extract, biotin, hair root activator such as pentadecanoic acid glyceride, glycyrrhizic acid and its derivatives, anti-inflammatory agents such as β-glycyrrhetinic acid, allantoin, azulene, ε-aminocaproic acid, hydrocortisone, vitamins A, B 2 , B 12 , D and the like, and amino acids such as cysteine, serine, methionine, leucine and tryptophan, and many other hair growth and hair growth components have been used. Further, mainly for the treatment and improvement of male pattern baldness, testosterone 5α- catalyzes the conversion of testosterone to active dihydrotestosterone.
Many that inhibit reductase activity have been screened. Known inhibitors of the enzyme include steroid substances such as progesterone and deoxycorticosterone, as well as extracts of various types of plants. Also, oxendrone, spironolactone, cyproterone acetate, and the like are said to inhibit dihydrotestosterone from binding to its receptor. [0005] However, some of the conventionally used hair-growth and hair-growth components and testosterone 5α-reductase inhibitors have side effects, such that the amount that can be incorporated is limited or the effect is insufficient. In many cases, there are problems such as poor stability in the preparation for external use for the head such as a hair restorer, or difficulty in obtaining a certain quality. Accordingly, the present invention is applicable to hair loss and alopecia caused by various causes in addition to male pattern baldness, and has an effect of preventing hair loss and hair growth and hair growth. It is an object of the present invention to provide an external preparation for a head, such as a hair nourishing agent, which is synergistically improved and highly safe for the scalp. [0007] In order to solve the above problems, various studies have been made. As a result, Agaricus blanc
zei Murill) One or more selected from mycelium extract and culture filtrate, and sage ( Salvia officinalis)
L.), hops ( Humulus lupulus L.), rosemary ( Rosmarinus officinalis L.), Hypericum ( Hyper
icum erectum Thunb.), Mentha ( Mentha arvensis L.)
var. piperascens Malinv.), peppermint (Mentha
piperita L.), chamomile ( Matricaria chamomilla )
L.), Arnica ( Arnica montana L.), Thyme ( Thymu
s vulgaris L.), one or two selected from each extract
It has been found that the combined use of more than two or more species synergistically improves hair loss prevention and hair growth and hair growth effects. Also, extracts of Agaricus blazei Murill mycelium or culture filtrate, and each extract such as sage show a sufficiently effective action at a low concentration, respectively, so that skin irritation and contact sensitization No adverse effects were observed, and both showed stable quality. [0008] Agaricus blazei Murill
Is a kind of agaric genus of the basidiomycete agaricaceae agaricaceae, also known as Kawari agaric or Himematsutake. Agaricus mushrooms are distributed in the southeastern and southern parts of North America, and in the southeastern part of Brazil, are a type of mushroom that has been used by residents for a long time. Many reports have been made on the effectiveness of this Agaricus mushroom, especially on its antitumor activity. For example,
A polysaccharide having an antitumor effect can be obtained by extracting the fruit body or mycelium of Agaricus mushroom with an aqueous solvent (JP-A-55-74797, JP-A-55-108).
292, JP-A-1-67194, JP-A-1
JP-A-67195, JP-A-6-128164, etc.), that a nucleic acid component having an antitumor effect can be obtained from the fruit body of Agaricus mushroom (JP-A-1-66127), from the hot water extraction residue of Agaricus mushroom Isolation of a protein polysaccharide having antitumor activity (JP-A-2-7863)
No. 0), that a glycoprotein having an antitumor activity can be obtained from an 85% ethanol extraction residue of Agaricus mushroom (Japanese Patent Laid-Open No. 6-9423), and that ergosterol having an antitumor activity present in the fruit body of Agaricus mushroom Derivatives (JP-A-1-246299) and the like are disclosed. In addition, as a physiological activity of Agaricus mushroom, a liver function improving agent containing an Agaricus mushroom fruit body extract as an active ingredient (Japanese Patent Laid-Open No. 2-124)
No. 829), the antiallergic effect of the Agaricus mushroom mycelium culture extract (Japanese Patent Application Laid-Open No. 1-228480), and the effect of the Agaricus mushroom fruiting body extract on the reduction of the immune function (Japanese Patent Application Laid-Open No.
-258107) and the like. further,
It has already been disclosed that the Agaricus mushroom mycelium extract or the culture filtrate has a hair root activating effect (Japanese Patent Application No. 9-1997).
366848). On the other hand, sage ( Salvia officinalis)
L.), hops ( Humulus lupulus L.), rosemary ( Rosmarinus officinalis L.), Hypericum ( Hyper
icum erectum Thunb.), Mentha ( Mentha arvensis L.)
var. piperascens Malinv.), peppermint (Mentha
piperita L.), chamomile ( Matricaria chamomilla )
L.), Arnica ( Arnica montana L.), Thyme ( Thymu
s vulgaris L.), one or two selected from each extract
More than one species are disclosed to have testosterone 5α-reductase inhibitory activity (Japanese Patent Publication No. 6-47).
554). [0010] The present inventors have now developed one or more selected from a solvent extract of Agaricus mushroom mycelium and a culture filtrate, and sage ( Salvia officinalis L.), hop ( Humul ).
us lupulus L.), rosemary ( Rosmarinus officina)
lis L.), Hypericum erectum Thun
b.), mint ( Mentha arvensis L. var. piperascens
Malinv.), Mentha Piperita L.,
Chamomile ( Matricaria chamomilla L.), Arnica ( Ar
nica montana L.) and thyme ( Thymus vulgaris L.) by combining them with one or more selected from each extract in a base for external use for the head such as a hair restorer.
The present inventors have found that the hair loss preventing action and the hair growth and hair growth actions are synergistically improved, thereby completing the present invention. DETAILED DESCRIPTION OF THE INVENTION Agaricus mushroom ( Aga) used in the present invention
ricus blazei Murill) is already widely known and has been deposited with the National Institute of Advanced Industrial Science and Technology under the deposit number of Life Science Bacteria No. 4731. As a method for cultivating the mycelium of Agaricus mushrooms, any of a solid culture method and a liquid culture method usually used for cultivation of basidiomycetes may be employed, but the latter method is preferably used from the viewpoint of productivity. . The culture medium may be any medium as long as it contains various nutrients necessary for the growth of mycelium, and an ordinary medium can be used. That is, as the carbon source, any carbon source that can be used, such as glucose, sucrose, maltose, and starch, can be used. Examples of the nitrogen source include ammonium sulfate, ammonium nitrate, and urea. Examples of natural complex nutrients include potato extract, carrot extract, malt extract, peptone, koji extract, yeast extract, yeast powder, and the like. In addition, trace elements such as inorganic salts and vitamins necessary for growth are appropriately added and used. The cultivation is usually preferably carried out under aerobic conditions, for example, a shaking culture method or an aeration stirring culture method. The stirring during the culture may be performed by reciprocating or rotating for several minutes every 24 hours, or may be performed by continuous shaking. The culture temperature is 15 ° C to 40 ° C, preferably 20 ° C to 3 ° C.
It is around 0 ° C. The pH of the medium is suitably in the range of 3.0 to 9.0, and particularly 4.5 to 7.0, and the growth is good. In addition, it is preferable not to illuminate during culturing, but 11 to 1 day a day.
Illumination for about 4 hours is possible. The number of culture days varies depending on culture conditions such as culture temperature and medium composition, but may be any period during which sufficient growth of mycelium is observed, and is usually 2 to 120 days, particularly preferably 5 to 90 days. What is necessary is just to set the period in which the mycelium production is maximized. After completion of the culture, the mycelium and the culture filtrate are separated by centrifuging or filtering the culture. Centrifugation is 100-5,000 G, preferably 800-3,000.
It can be performed by a centrifugal operation giving a gravitational acceleration of G. The filtration is performed using a membrane filter of 3.5 to 200 mesh, particularly preferably 4 to 16 mesh. When an extract is obtained from the mycelium of Agaricus mushroom, the mycelium obtained from the culture solution cultured as described above can be used as it is or after drying. As the solvent for extraction from the mycelium, a polar solvent is preferably used. For example, in addition to water, alcohols such as methanol, ethanol, isopropanol and isobutanol, glycerin, ethylene glycol, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, propylene glycol, propylene glycol monomethyl ether, propylene glycol monoethyl ether, triglycol Polyhydric alcohols such as ethylene glycol, 1,3-butylene glycol and hexylene glycol or derivatives thereof, ethers such as ethyl ether and propyl ether, esters such as ethyl acetate and butyl acetate, ketones such as acetone and ethyl methyl ketone One or a mixture of two or more solvents selected from the above-mentioned types can be used. Further, physiological saline, phosphate buffer, phosphate buffered saline, or the like may be used. Further, as an extraction method, a method of extracting by impregnating with an extraction solvent at room temperature, cooling or heating, a method of extracting using a distillation method such as steam distillation, and a method of directly compressing raw Agaricus mushroom mycelium. Examples of such methods include a squeezing method for obtaining an extract, and these methods are used alone or in combination of two or more. The ratio of Agaricus mushroom mycelium to the solvent at the time of extraction is not particularly limited, but the solvent is 0.5 to 1,000 times by weight with respect to Agaricus mushroom mycelium 1, especially the extraction operation and efficiency. In view of this, the weight is preferably 0.5 to 100 times by weight.
The extraction temperature is conveniently in the range from about 5 ° C. under normal pressure to the boiling point of the solvent or lower, and the extraction time varies depending on the extraction conditions such as the extraction temperature, but is preferably in the range of 2 hours to 2 weeks. . The agaricus mushroom mycelium extract thus obtained can be used as it is, but it can be fractionated, deodorized and deodorized within a range that does not impair the hair root activating effect.
A purification operation such as decolorization and concentration can be used.
These extracts, purified products and fractionated products can be made into powder by concentration to dryness or freeze-drying, and further solubilized or suspended in a solvent such as purified water or the like, and a hair nourishing agent or other external preparation for the head. Can also be added. On the other hand, the filtered mycelium culture filtrate that has been filtered can be directly added to an external preparation for the head. However, purification, such as fractionation, deodorization, decolorization, and concentration, is also performed within a range that does not lose the hair root activating action. It can also be used with additional operations. These culture filtrates, purified products, and fractionated products can be dried by removing the solvent therefrom, and can be further solubilized or suspended in a solvent such as purified water, or in the form of an emulsion. Can be added to the external preparation for the head. From the Agaricus mushroom mycelium extract and the mycelium culture filtrate, one or more are selected and blended into an external preparation for the head such as a hair restorer. The amount of the compound varies depending on the extraction method and other preparation methods, but is preferably in the range of 0.0001 to 10% by weight in consideration of bioavailability and influence on the preparation. On the other hand, sage ( Salvia officinalis L.)
Such plant extracts are obtained by immersing these plants in an extraction solvent. For extraction, each part such as a flower, a leaf, a stem, a root and the like of each plant and a whole plant can be used. These plants may be subjected to an extraction treatment as it is, but in order to increase the extraction efficiency, it is preferable to extract after shredding, pulverizing or the like, or to homogenate in an extraction solvent. As the extraction solvent, a polar solvent is preferable. In addition to water, lower alcohols such as methanol, ethanol, propanol, isopropanol and butanol, propylene glycol, dipropylene glycol,
Preferred are polyhydric alcohols such as 1,3-butylene glycol and glycerin, ethers such as ethyl ether and propyl ether, esters such as ethyl acetate and butyl acetate, and ketones such as acetone and ethyl methyl ketone. And one or more of these are selected and used. Phosphate buffer, physiological saline, and phosphate buffered saline can also be used favorably. Extraction with ethanol is particularly preferred from the viewpoint of testosterone 5α-reductase inhibitory activity. 5-5 as extraction temperature
About 0 ° C. and an extraction time of about 4 hours to about 1 week are appropriate. The above-mentioned plant extract may be added as it is to a base for external use for the head such as a hair tonic, etc., but the concentrated and dried one may be dissolved again in water or a polar solvent, or testosterone may be added.
It may be added after performing a purification treatment such as decolorization, deodorization, and desalting to the extent that 5α-reductase inhibitory activity is not impaired. After concentration and drying, or after performing a purification treatment,
It may be freeze-dried and added as a powder. In the present invention, 1% of the above plant extract is used.
A seed or two or more kinds are selected and blended in the external preparation for head. The amount to be blended also varies depending on the testosterone 5α-reductase inhibitory activity of the extract, but is 0.0001 to 10
It is appropriate to set it to about% by weight. In the external preparation for head according to the present invention, one or more selected from the active ingredients of Agaricus mushroom mycelium extract and culture filtrate, and sage ( Salvia o.
fficinalis L.), hops ( Humulus lupulus L.), rosemary ( Rosmarinus officinalis L.), hypericum ( Hypericum erectum Thunb.), peppermint ( Mentha a )
rvensis L. var. piperascens Malinv.) , peppermint (Mentha piperita L.), chamomile (Matricaria c
hamomilla L.), Arnica ( Arnica montana L.), Thymus ( Thymus vulgaris L.) In addition to one or more selected from each extract, in order to further enhance hair growth and hair growth promotion effect, Estrogen, such as estrone, estradiol, ethinyl estradiol, vitamin E and its derivatives, assembly extract, garlic extract, carrot extract, aloe extract, cepharanthin, carpronium chloride, minoxidil, etc., peripheral blood flow promoters, capsicum tincture , Cantaris tincture, Showa tincture,
Topical stimulants such as peppermint oil, l-menthol and camphor; keratolytic agents such as resorcinol, salicylic acid and lactic acid; antiseborrheic agents such as pyridoxine and its derivatives; zinc pyrithione;
Fungicides such as benzalkonium chloride, benzethonium chloride, chlorhexidine, hinokitiol, pantothenic acid and its derivatives, placental extracts, hair root activators such as biotin and pentadecanoic acid glyceride, glycyrrhizic acid and its derivatives, β-glycyrrhetinic acid and its derivatives , Allantoin, azulene, ε-aminocaproic acid, hydrocortisone, etc., vitamins such as vitamins A, B 2 , B 12 , D, cysteine, serine, methionine, leucine,
Amino acids such as tryptophan can be simultaneously added. Further, as long as the effects of the present invention are not impaired, oils and fats, lower alcohols, polyhydric alcohols, surfactants, humectants, fungicides and fungicides, ultraviolet absorbers, fragrances,
Raw materials and additives generally used in an external preparation for the head such as a hair nourishing agent such as pigments and pigments can be contained. The external preparation for the head according to the present invention can be provided in the form of a lotion, emulsion, gel, cream, ointment or the like. It can also be provided as a head cosmetic in the form of hair lotion, hair tonic, hair milk, hair gel, hair cream, hair pack, hair treatment, hair shampoo, hair rinse. EXAMPLES Further, the features of the present invention will be described in detail with reference to examples. First, examples of production of Agaricus mushroom mycelium extract, Agaricus mushroom mycelium culture filtrate, and plant extracts such as sage used in Examples of the present invention are shown below. Production Example 1 Agaricus mushroom mycelium extract 1 An Agaricus mushroom mycelium extract 1 was obtained by the method described in Example 1 of JP-B-61-47518. That is, a pH consisting of 4 g of glucose, 4 g of yeast extract, 10 g of malt extract and 1,000 ml of purified water.
The medium of 5.5 was inoculated with Agaricus mushroom mycelium cultured on an agar medium, and pre-cultured at 30 ° C. for 30 days with occasional stirring and standing. Then, glucose 20g, yeast powder 5
g, an antifoaming agent of 20 ppm and purified water of 1,000 ml, and 2,000 ml of a main culture medium having a pH of 5.0 were inoculated with 200 ml of the precultured medium, and cultured at 30 ° C. for 30 days with a reciprocating shaker. The mycelium was separated from the culture solution by centrifugation, purified water was added 7 times by weight to the mycelium, and the
Heat extraction was performed at 2 ° C. for 2 hours. The supernatant obtained by centrifuging the extract was subjected to Agaricus mushroom mycelium extract 1 (Production Example 1).
And [Production Example 2] Agaricus mushroom mycelium extract 2 The above Agaricus mushroom mycelium extract 1 was concentrated to 容量 volume, ethanol was added to the same volume, and the mixture was allowed to stand at 4 ° C. for 24 hours to form a precipitate. I let it. The precipitate was collected by centrifugation, washed with acetone and then with ether, and dried to obtain a light brown powder. Agaricus mushroom mycelium extract 2 (Production Example 2)
And Production Example 3 Agaricus mushroom mycelium extract 3 An Agaricus mushroom mycelium extract 3 was obtained by the method described in Example 2 of JP-B-61-47518. That is, agaricus mycelia cultured on an agar medium was inoculated into a pH 5.0 medium consisting of 20 g of glucose, 5 g of yeast extract and 1,000 ml of purified water, and then inoculated into the medium.
Preculture was carried out by standing at ℃ for 3 weeks. 500 ml of this preculture
With 50 g of glucose, 10 g of yeast powder and 20 pp of an antifoaming agent
m and 1,000 ml of purified water were inoculated into 3,000 ml of a main culture medium having a pH of 5.0, and cultured under conditions of a culture temperature of 30 ° C., an aeration rate of 0.5 VVM, and a stirring speed of 200 to 300 rpm. After culturing for 10 days, the mycelium was separated and collected by filtration. 3,000 ml of purified water was added to the mycelium, and the mixture was heated and extracted at 50 ° C. for 1 hour. After cooling, 10,000
The mixture was centrifuged at 0 rpm for 30 minutes, and the supernatant was used as Agaricus mushroom mycelium extract 3 (Production Example 3). Production Example 4 Agaricus mushroom mycelium extract 4 Agaricus mushroom mycelium extract 3 was concentrated under reduced pressure using a rotary evaporator to 1,000 ml. 1,000 ml of ethanol was added thereto, and the mixture was allowed to stand at 4 ° C. for a day and night to form a precipitate. Next, the precipitate was recovered, washed with acetone and ether, and dried to obtain a pale gray-white powder. This was further dissolved in 500 ml of purified water, dialyzed against 5,000 ml of purified water with a dialysis tube, and the resulting precipitate was removed by centrifugation. The supernatant was freeze-dried to obtain a white powder. Agaricus mushroom mycelium extract 4 (Production Example 4). [Preparation Example 5] Agaricus mushroom mycelium culture filtrate 1 At the time of preparation of Preparation Example 1, the culture liquid after removing the mycelia from the main culture liquid of the Agaricus mushroom mycelium was used as the Agaricus mushroom mycelium culture filtrate 1 ( Production Example 5) was obtained. Production Example 6 Agaricus mushroom mycelium culture filtrate fraction 1 Agaricus mushroom mycelium culture filtrate 1 was concentrated to 1/6 volume with a rotary evaporator, and an equal volume of ethanol was added thereto. The mixture was allowed to stand overnight and a precipitate was formed.
The precipitate was collected by centrifugation, washed with acetone and ether, and then dried to obtain a light brown powder, which was used as Agaricus mushroom mycelium culture filtrate fraction 1 (Production Example 6). [Preparation Example 7] Agaricus mushroom mycelium culture filtrate 2 At the time of preparation of Preparation Example 3, the culture liquid after removing the mycelium from the Agaricus mushroom mycelium main culture solution was used as the Agaricus mushroom mycelium culture filtrate 2 (manufactured). Example 7). Production Example 8 Agaricus mushroom mycelium culture filtrate fraction 2 Agaricus mushroom mycelium culture filtrate 2 was concentrated to 1/10 volume by a rotary evaporator, and an equal volume of ethanol was added thereto. To generate a precipitate. The precipitate was collected by centrifugation, washed with acetone and ether, and dried to obtain a light brown powder. This is purified water 30
0 ml, purified water 3,000m with dialysis tube
After dialysis against 1 and removing the resulting precipitate by centrifugation, the supernatant was freeze-dried to obtain a white powder, which was used as a filtrate fraction 2 of Agaricus mushroom mycelium culture (Production Example 8). [Production Examples 9 to 26] The plants shown in the second column of Table 1 were minced, and immersed in each solvent shown in the third column of Table 1 at 20 ° C. for 3 days to perform extraction. The filtrate obtained by filtering the extract was further treated as shown in the fourth column of Table 1 to obtain extracts such as sage (Production Examples 9 to 26). [Table 1] Using the above-mentioned production examples, the hair growth promoting effect of a combined use of an agaricus mushroom mycelium extract or a culture filtrate with a plant extract such as sage was examined. C57 / Blac
The back of the k-mouse was shaved with a clipper to a size of 2 × 4 cm, treated with a depilatory foam to completely remove hair, and after 24 hours, 0.1 ml of each sample solution shown in Table 2 was used once a day. Each was continuously applied for 20 days. All hairs that grew on the last day of the test were extracted, and their total weight was measured. The test was performed with 10 animals per group, and the average value was calculated and shown in Table 3. At that time, a group to which only a 50% by weight aqueous ethanol solution of a solvent was applied was set as a control. [Table 2] [Table 3] As is clear from Table 3, the Agaricus mushroom mycelium extract or the culture filtrate of Production Examples 1 to 8 and the plant extract of Production Examples 9 to 26 were compared with the control in the group applied alone. Although hair growth was significantly enhanced in comparison, when these were used in combination, the amount of hair growth was significantly increased. [Examples 1 to 8] Hair Nourishing Lotion A hair nourishing lotion was prepared using the Agaricus mushroom mycelium extract or the culture filtrate and the plant extract shown in Table 4 according to the following formulation. (Prescription) (1) Ethanol 50.00 (% by weight) (2) Vitamin B 6 0.10 (3) Agaricus mushroom mycelium extract 0.05 or culture filtrate (4) Plant extract 0.50 (5) 1,3-butylene glycol 2.50 (6) Fragrance 0.10 (7) Purified water 46.75 Production method: (1) to (6) are sequentially added to (7) and mixed to make uniform. [Table 4] A use test was conducted for Examples 1 to 8 to evaluate the hair-growth effect. At that time, in the above Examples 1, 2, 5, and 6, the agaricus mushroom mycelium extract or the culture filtrate was replaced with purified water to obtain Comparative Example 1, Comparative Example 2, Comparative Example 5, and Comparative examples 6, Comparative examples 4, Comparative examples 7 and 8 were obtained by replacing the plant extract with purified water in Comparative example 6, Example 3, Example 4, Example 7 and Example 8. Further, Agaricus The same test was performed as Comparative Example 9 except that both the mushroom mycelium extract or the culture filtrate and the plant extract were replaced with purified water. In the use test, 20 male and female panelists who were worried about thinning hair and hair loss were treated as a group, and each of the examples and comparative examples was used blindly twice a day for 6 consecutive months. Evaluation was made on the status of improvement of hair loss symptoms and the presence or absence of irritation during use. The state of improvement of the hair thinning and hair loss symptoms was evaluated by scoring the condition of the hair before and after the start of the use test according to the criterion shown in Table 5 by photography and scored, and the average value of 20 subjects was calculated. Regarding irritation during use, "I do not feel; 0 points",
Points were scored as "feel slightly; 1 point", "slightly felt; 2 points", "clearly felt; 3 points", and "very much felt; 4 points", and the average value of 20 people was obtained. The above results are summarized in Table 6. [Table 5] [Table 6] As is clear from Table 6, in the group using the examples of the present invention, in each group, most of the panelists showed hair growth and hair growth more than the whole raw hair, and the panelers who saw hard hair were further observed. And a very good hair loss symptom and improvement of thinning hair were observed. In contrast,
Comparative Examples 1 to 8 containing only one of the Agaricus mushroom mycelium extract or culture filtrate, or the plant extract
In the application group, improvement of hair loss symptoms and thinning hair was observed,
The degree was smaller than that in each of the applied groups.
In the group to which Comparative Example 9 was applied, which did not contain any of the Agaricus mushroom mycelium extract, the culture filtrate, and the plant extract, no significant change was observed in the hair condition. Regarding the feeling of irritation during use, no particularly problematic feeling of irritation was observed in any of Examples 1 to 8 and Comparative Examples 1 to 9 of the present invention. Next, the formulation of another embodiment of the present invention will be described. Example 9 Head Cream (1) Liquid Paraffin 15.00 (% by weight) (2) Vaseline 15.00 (3) Beeswax 2.00 (4) Polyoxyethylene (50E.O.) Hardened castor oil 3.00 (5) Glycerin 5.00 (6) Carboxyvinyl polymer 0.10 (7) Xanthan gum 0.10 (8) Disodium ethylenediaminetetraacetate 0.10 (9) Purified water 59.10 (10 ) Sodium hydroxide 0.05 (11) Agaricus mushroom mycelium extract 1 (Production Example 1) 0.25 (12) Thyme extract (Production Example 25) 0.15 (13) Sage extract (Production Example 9) 0.15 Production method; heat and dissolve the oil phase of (1) to (3) to 80 ° C. On the other hand, the aqueous phase components (4) to (9) are mixed and dissolved by heating to 80 ° C. The oil phase was added to the water phase while stirring, and the mixture was uniformly emulsified by a homogenizer. After cooling, (10) was added at 30 ° C., and after mixing, (11) to (13) were previously mixed, dissolved, and added. Mix and homogenize. Example 10 Head Gel (1) Carboxyvinyl polymer 0.7 (% by weight) (2) Polyvinylpyrrolidone 2.0 (3) Glycerin 5.0 (4) Sodium hydroxide 0.2 (5) Ethanol 20.0 (6) Disodium ethylenediaminetetraacetate 0.1 (7) Purified water 70.8 (8) Agaricus mushroom mycelium extract 2 (Production Example 2) 0.2 (9) Hop extract (Production Example 11) 1.0 Production method: (1) is dispersed in a part of (3) and (7). (2),
Dissolve (4) to (6) in the remainder of (7) and add (8) and (9)
Is mixed, dissolved and added in advance, and mixed and homogenized. Example 11 Set lotion (1) Polyvinylpyrrolidone / vinyl acetate copolymer 5.00 (% by weight) (2) Methyl paraoxybenzoate 0.10 (3) Fragrance 0.10 (4) Ethanol 30 0.00 (5) Polyoxyethylene / polyoxypropylene modified 0.50 Dimethyl polysiloxane (6) Glycerin 2.00 (7) Agaricus mushroom mycelium extract 3 (Production Example 3) 0.01 (8) Rosemary extraction (Production Example 13) 0.25 (9) Purified water 62.04 Production method: (1) to (3) are sequentially added to (4) and dissolved. On the other hand (5)
The aqueous phases of (9) to (9) are mixed and dissolved, and added to the above solution, mixed, and made uniform. Example 12 Hair Liquid (1) Ethanol 50.00 (% by weight) (2) Polyoxypropylene (40 PO) butyl ether 20.00 (3) Polyoxyethylene (50 EO) cured Castor oil 1.00 (4) Methyl paraoxybenzoate 0.15 (5) Agaricus mushroom mycelium extract 4 (Production Example 4) 0.10 (6) Hypericum extract (Production Example 15) 0.50 (7) Mint extract (Production Example 17) 1.00 (8) Fragrance 0.10 (9) Blue No. 1 (1% aqueous solution) 0.10 (10) Purified water 27.05 Production method: (2)-(1) The components of (10) are sequentially added and dissolved to make them uniform. Example 13 Water Grease (1) Carboxyvinyl polymer 0.5 (% by weight) (2) Glycerin 50.0 (3) Purified water 38.5 (4) Polyoxyethylene (20E.O.) Octyldodecyl 0.2 Ether (5) Sodium hydroxide 0.1 (6) Ethanol 10.0 (7) Agaricus mushroom mycelium culture filtrate 1 (Production Example 5) 0.2 (8) Agaricus mushroom mycelium culture filtrate Painting 2 (Production Example 8) 0.2 (9) Chamomile extract (Production Example 21) 0.2 (10) Fragrance 0.1 Production method: (1) is dispersed in (2) and part of (3) I do. (4),
(6) to (10) are dissolved and added to the remainder of (3), and then (5) is added to thicken. [Example 14] Hair foam (stock solution formulation) (1) Silicone oil 5.00 (% by weight) (2) Polyoxyethylene (50E.O.) hydrogenated castor oil 1.00 (3) Dipropylene glycol 7.00 (4) Cationized cellulose 3.00 (5) Purified water 67.00 (6) Ethanol 15.00 (7) Agaricus mushroom mycelium culture filtrate fraction 1 (Production Example 6) 0.25 (8 ) Common peppermint extract (Production Example 19) 1.50 (9) Methyl paraoxybenzoate 0.15 (10) Fragrance 0.10 (filling formulation) Stock solution 90.0 Liquefied petroleum gas 10.0 Production method: (1) Add to the melts of (2) and (3) and emulsify uniformly with a homogenizer. This is added to and dissolved in (4), (6) to (10) dissolved in (5), and mixed to make a uniform solution. Filling is performed by filling a can with a stock solution, mounting a valve, and then filling with liquefied petroleum gas. Example 15 Hair Shampoo (1) Polyoxyethylene (3E.O.) Lauryl Sulfate 30.00 (wt%) Ester Sodium Salt (30 wt% aqueous solution) (2) Lauryl Sulfate Sodium Salt 00 (30% by weight aqueous solution) (3) Coconut oil fatty acid diethanolamide 4.00 (4) Glycerin 1.00 (5) Sodium dehydroacetate 0.20 (6) Disodium ethylenediaminetetraacetate 0.25 (7) Purified water 53.55 (8) Agaricus mushroom mycelium culture filtrate 2 (Production Example 7) 0.50 (9) Arnica extract (Production Example 23) 0.20 (10) Thyme extract (Production Example 26) 0.20 ( 11) Fragrance 0.10 Production method: (7) is heated to 70 ° C, (1) to (6) are added and uniformly dissolved, then cooled, and (8) to (11) are added and mixed at 30 ° C. ,
Be uniform. Example 16 Hair rinse (1) Silicone oil 3.00 (% by weight) (2) Liquid paraffin 1.00 (3) Cetanol 1.50 (4) Stearyl alcohol 1.00 (5) Stearyl trimethyl chloride Ammonium 0.70 (6) Glycerin 3.00 (7) Methyl paraoxybenzoate 0.20 (8) Purified water 88.92 (9) Agaricus mushroom mycelium extract 2 (Production Example 2) 0.02 (10) Agaricus mushroom mycelium culture filtrate fraction 1 (Production Example 6) 0.02 (11) Sage extract (Production Example 10) 0.02 (12) Hop extract (Production Example 12) 0.02 (13) Thyme Extract (Production Example 26) 0.50 (14) Fragrance 0.10 Production method: The oil phase components (1) to (4) and the aqueous phase components (5) to (8) were mixed and dissolved, Heat to ° C. The oil phase is added to the water phase to emulsify, and after cooling, (9) to (14) are previously mixed, dissolved and added at 30 ° C., and mixed and homogenized. The above-described embodiments 1 to 16 of the present invention
In each case, the stability was good, and even when stored at 25 ° C. for 6 months, no change in the state such as a change in color and odor, phase separation, appearance of precipitates and sediments was observed. Also, as a result of a 48-hour back obstruction sticking test by a male panelist, no skin irritation was observed. As described in detail above, the present invention can be applied to hair loss and alopecia caused by various causes in addition to male pattern baldness, and has an effect of preventing hair loss and hair growth and hair growth. Was synergistically improved and a highly safe external preparation for the head for the scalp could be provided.
───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 平11−193220(JP,A) 特開 平1−228480(JP,A) 特開 平7−316026(JP,A) 特開 平9−328415(JP,A) 特開 平9−221413(JP,A) 特開 平8−310923(JP,A) (58)調査した分野(Int.Cl.7,DB名) A61K 7/00 - 7/50 JICSTファイル(JOIS) CA(STN)──────────────────────────────────────────────────続 き Continuation of the front page (56) References JP-A-11-193220 (JP, A) JP-A-1-228480 (JP, A) JP-A-7-316026 (JP, A) JP-A 9-1998 328415 (JP, A) JP-A-9-221413 (JP, A) JP-A-8-310923 (JP, A) (58) Fields investigated (Int. Cl. 7 , DB name) A61K 7/00-7 / 50 JICST file (JOIS) CA (STN)
Claims (1)
l)菌糸体の抽出物、及びアガリクス茸(Agaricus blaz
ei Murill)菌糸体培養濾液より選択される1種又は2
種以上と、セージ(Salvia officinalis L.),ホップ
(Humulus lupulus L.),ローズマリー(Rosmarinus o
fficinalis L.),オトギリソウ(Hypericum erectum T
hunb.),ハッカ(Mentha arvensis L. var. piperasce
ns Malinv.),セイヨウハッカ(Mentha piperita
L.),カミツレ(Matricaria chamomilla L.),アルニ
カ(Arnica montana L.),タイム(Thymus vulgaris
L.)の各抽出物より選択される1種又は2種以上とを含
有して成る、頭部用外用剤。(57) [Claims] (Claim 1) Agaricus blazei Muril
l) Mycelium extract and Agaricus blaz
ei Murill) One or two selected from mycelium culture filtrate
More than species, sage ( Salvia officinalis L.), hop ( Humulus lupulus L.), rosemary ( Rosmarinus o.)
fficinalis L.) and Hypericum ( Hypericum erectum T)
hunb.), peppermint (Mentha arvensis L. var. piperasce
ns Malinv.), Mentha piperita
L.), chamomile ( Matricaria chamomilla L.), arnica ( Arnica montana L.), thyme ( Thymus vulgaris )
An external preparation for the head, comprising one or more selected from the extracts of L.).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP04139098A JP3382149B2 (en) | 1998-02-05 | 1998-02-05 | External preparation for head |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP04139098A JP3382149B2 (en) | 1998-02-05 | 1998-02-05 | External preparation for head |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH11228355A JPH11228355A (en) | 1999-08-24 |
| JP3382149B2 true JP3382149B2 (en) | 2003-03-04 |
Family
ID=12607058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP04139098A Expired - Fee Related JP3382149B2 (en) | 1998-02-05 | 1998-02-05 | External preparation for head |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3382149B2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008179540A (en) * | 2005-01-07 | 2008-08-07 | Noevir Co Ltd | Substances that control cell differentiation, development, and proliferation, and cell differentiation, development, and growth regulators containing the substances |
| JP4999276B2 (en) * | 2005-02-09 | 2012-08-15 | 丸善製薬株式会社 | Hair papilla cell growth promoter and hair restorer |
| GB2465551A (en) * | 2008-11-18 | 2010-05-26 | Auron Invest Ltd | Compositions comprising Chamomilla plant extracts and their use in treating hair root disorders |
| JP7450903B2 (en) * | 2018-07-25 | 2024-03-18 | 一丸ファルコス株式会社 | Preadipocyte proliferation and differentiation promoter |
-
1998
- 1998-02-05 JP JP04139098A patent/JP3382149B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11228355A (en) | 1999-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5663160A (en) | Cosmetic or dermatological composition containing at least one saponin of the ginsenoside type, and its applications, especially for treating the hair | |
| JP3415198B2 (en) | External preparation for skin | |
| JP7135106B2 (en) | Scalp and hair composition | |
| JP2003176213A (en) | Hair restorer | |
| JP3382149B2 (en) | External preparation for head | |
| US20020150547A1 (en) | Composition of hair growth facilitator | |
| JP3505200B2 (en) | Hair restorer | |
| JPH1160450A (en) | Hair tonic | |
| JP2002332240A (en) | Hair restorer composition | |
| JP3382148B2 (en) | External preparation for head | |
| JP2003137742A (en) | Hair growing agent comprising evolvulus plant extract and other galenical extract | |
| JPH07145033A (en) | Cosmetic for prevention of dermal aging | |
| JP2019182771A (en) | Poria sclerotium fermentation extract and method for producing the same | |
| JP3382135B2 (en) | External preparation for hair | |
| JP3643691B2 (en) | Skin preparation | |
| JP3382142B2 (en) | Hair restorer and hair cosmetic | |
| JP2006045157A (en) | Hair tonic | |
| JPH1087440A (en) | Hair tonic cosmetic | |
| JPH06135821A (en) | Hair tonic | |
| JP2774071B2 (en) | Hair restoration cosmetics | |
| JPH07316026A (en) | Hair care product | |
| JP2811479B2 (en) | Hair restoration | |
| JP2010095496A (en) | Production conditioner for hair-growing cytokine, and hair grower, quasi-drug and cosmetic each incorporated with production conditioner for growing the cytokine | |
| JPH05186314A (en) | Hair growing agent composition | |
| JP2003221314A (en) | Skin care preparation for external use to be used for hair growth |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071220 Year of fee payment: 5 |
|
| RD05 | Notification of revocation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D05 |
|
| LAPS | Cancellation because of no payment of annual fees |